Submitted by Anonymous (not verified) on 24 June 2026 - 16:52
Human medicines European public assessment report (EPAR): Yervoy, ipilimumab, Date of authorisation: 13/07/2011, Revision: 60, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Yervoy, ipilimumab, Date of authorisation: 13/07/2011, Revision: 60, Status: Authorised